Local 12: Doctors explain treatments for clinical depression
Pennsylvania Senator John Fetterman recently announced he is being treated for clinical depression. While not commenting directly on Fetterman's care, the University of Cincinnati's Caleb Adler spoke with Local 12 on effective treatments for clinical depression.
Fetterman suffered a stroke last year, and Adler noted about one-third of patients who have had a stroke or brain injury experience clinical depression. Therapy for patients like this often focuses on positivity, he said.
"Keeping a positive outlook, recognizing that one can recover, that a stroke is not a death sentence or doesn’t have to be debilitating,” said Adler, MD, professor and vice chair of research; co-director of the Division of Bipolar Disorders Research; and director of the Center for Imaging Research in the University of Cincinnati College of Medicine's Department of Psychiatry and Behavioral Neuroscience.
Adler said outside of talk therapy and medication, other effective treatments include electroconvulsive therapy and transcranial magnetic stimulation.
Editor's note: If you are experiencing a suicide or mental health crisis, call or text 988 to connect directly to the Suicide and Crisis Lifeline.
Watch or read the Local 12 report.
Featured photo at top courtesy of iStock.
Related Stories
Enquirer: Experts discuss reasons for drop in overdose deaths
April 12, 2023
The University of Cincinnati's Christine Wilder, MD, spoke with the Cincinnati Enquirer about Hamilton County data that overdose deaths in 2022 dropped for the first time in six years.
U.S. News & World Report: Metformin may help young patients with bipolar disorder avoid weight gain
October 31, 2023
U.S. News & World Report highlighted recent research led by the University of Cincinnati and Northwell Health that found the drug metformin can help prevent or reduce weight gain in youth taking medication to treat bipolar disorder.
Cape Girardeau, Missouri news highlights UC clinical trial
February 20, 2024
KFVS-TV in Cape Girardeau, Missouri highlighted a University of Cincinnati clinical trial testing a wearable neurostimulation device to help patients with opioid use disorder and post-traumatic stress disorder stick with medication treatment while finding the right dose.